Anders Dahlin

476 total citations
14 papers, 329 citations indexed

About

Anders Dahlin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, Anders Dahlin has authored 14 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Genetics. Recurrent topics in Anders Dahlin's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Genital Health and Disease (2 papers). Anders Dahlin is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Genital Health and Disease (2 papers). Anders Dahlin collaborates with scholars based in United States, Sweden and United Kingdom. Anders Dahlin's co-authors include David Ulmert, Hans Lilja, Andrew J. Vickers, Jonas Manjer, Peter T. Scardino, Anders Bjartell, Angel M. Cronin, Caroline Savage, Amit Gupta and James A. Eastham and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and The Journal of Urology.

In The Last Decade

Anders Dahlin

13 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Dahlin United States 7 260 71 66 61 47 14 329
J. Reid United States 3 249 1.0× 72 1.0× 116 1.8× 50 0.8× 45 1.0× 8 301
Emanuela Fantinel Italy 11 299 1.1× 121 1.7× 118 1.8× 130 2.1× 47 1.0× 29 409
Shuang Hao China 9 80 0.3× 51 0.7× 71 1.1× 81 1.3× 12 0.3× 26 205
Meng‐Zhong Liu China 6 92 0.4× 122 1.7× 66 1.0× 117 1.9× 112 2.4× 7 321
Swan‐Swan Leong Singapore 6 291 1.1× 108 1.5× 70 1.1× 246 4.0× 62 1.3× 7 461
Tongliang Wang China 3 190 0.7× 65 0.9× 19 0.3× 29 0.5× 19 0.4× 6 269
Rebeca Lozano Spain 6 151 0.6× 61 0.9× 60 0.9× 94 1.5× 18 0.4× 21 207
Tamara Snow United States 5 119 0.5× 50 0.7× 117 1.8× 130 2.1× 25 0.5× 11 252
Ruixiao Lu United States 10 242 0.9× 78 1.1× 89 1.3× 69 1.1× 23 0.5× 24 337
Koveela Govindasami United Kingdom 9 318 1.2× 178 2.5× 110 1.7× 158 2.6× 28 0.6× 14 484

Countries citing papers authored by Anders Dahlin

Since Specialization
Citations

This map shows the geographic impact of Anders Dahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Dahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Dahlin more than expected).

Fields of papers citing papers by Anders Dahlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Dahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Dahlin. The network helps show where Anders Dahlin may publish in the future.

Co-authorship network of co-authors of Anders Dahlin

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Dahlin. A scholar is included among the top collaborators of Anders Dahlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Dahlin. Anders Dahlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Vertosick, Emily, Andrew J. Vickers, Anders Dahlin, et al.. (2025). Prostate-specific antigen levels at age 60 years and lifetime risk of lethal prostate cancer. JNCI Journal of the National Cancer Institute. 117(12). 2591–2597. 1 indexed citations
2.
Klein, Robert J., Emily Vertosick, David Ulmert, et al.. (2022). Prostate cancer polygenic risk score and prediction of lethal prostate cancer. npj Precision Oncology. 6(1). 25–25. 19 indexed citations
3.
Bicak, Mesude, Daniel D. Sjoberg, Emily Vertosick, et al.. (2020). Genome‐wide association study identifies novel single nucleotide polymorphisms having age‐specific effect on prostate‐specific antigen levels. The Prostate. 80(16). 1405–1412. 4 indexed citations
4.
Sjoberg, Daniel D., Andrew J. Vickers, Melissa Assel, et al.. (2018). Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men. European Urology. 73(6). 941–948. 35 indexed citations
5.
Middha, Mridu, Mesude Bicak, Daniel D. Sjoberg, et al.. (2018). Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival. European Urology. 74(6). 710–719. 44 indexed citations
7.
Klein, Robert J., Christer Halldén, Amit Gupta, et al.. (2011). Evaluation of Multiple Risk–Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men. European Urology. 61(3). 471–477. 41 indexed citations
8.
Vickers, Andrew J., Caroline Savage, Thomas Björk, et al.. (2011). 986 HOW SOON CAN WE IDENTIFY MEN AT HIGH RISK FOR PROSTATE CANCER DEATH? AN EARLY SURVEILLANCE STRATEGY FOR PROSTATE CANCER. The Journal of Urology. 185(4S). 1 indexed citations
9.
Vickers, Andrew J., Amit Gupta, Caroline Savage, et al.. (2011). A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening. Cancer Epidemiology Biomarkers & Prevention. 20(2). 255–261. 66 indexed citations
10.
Lilja, Hans, Caroline Savage, Thomas Björk, et al.. (2011). 1202 CAN AN EARLY PSA RULE OUT SUBSEQUENT ADVANCED PROSTATE CANCER? LONG TERM RISK OF ADVANCED CANCER IN MEN WITH LOW PSA LEVELS AT AGE BELOW 50. The Journal of Urology. 185(4S). 1 indexed citations
11.
Lilja, Hans, Angel M. Cronin, Anders Dahlin, et al.. (2010). Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50. Cancer. 117(6). 1210–1219. 103 indexed citations
12.
Vickers, Andrew J., A. Cronin, Thomas Björk, et al.. (2010). 982 LIFETIME RISK OF DEATH FROM PROSTATE CANCER PREDICTED BY KALLIKREIN MARKERS IN BLOOD TAKEN AT AGE 60. European Urology Supplements. 9(2). 308–308.
13.
Vickers, Andrew J., Angel M. Cronin, Jonas Manjer, et al.. (2009). PROSTATE SPECIFIC ANTIGEN LEVEL AT AGE 60 AND DEATH FROM PROSTATE CANCER. The Journal of Urology. 181(4S). 59–59. 1 indexed citations
14.
Lilja, Hans, Angel M. Cronin, Peter T. Scardino, et al.. (2008). A SINGLE PSA PREDICTS PROSTATE CANCER UP TO 30 YEARS SUBSEQUENTLY, EVEN IN MEN BELOW AGE 40. The Journal of Urology. 179(4S). 206–207. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026